EEG abnormalities and 3-year outcome in first episode psychosis

Acta Psychiatrica Scandinavica

Volumn 117, Issue 4, 2008, Pages 277-282

  Manchanda, R ^a,b   Norman, R ^b   Malla, A ^c   Harricharan, R ^b   Northcott, S ^b  

^a LONDON HEALTH SCIENCES CENTRE   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

Duration of untreated psychosis; EEG; First episode psychosis; Outcome; Schizophrenia

Indexed keywords

NEUROLEPTIC AGENT;

ADOLESCENT; ADULT; ANXIETY; ARTICLE; DEMOGRAPHY; DEPRESSION; DISEASE ASSOCIATION; DISEASE DURATION; EEG ABNORMALITY; ELECTROENCEPHALOGRAM; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; NEGATIVE SYNDROME; OUTCOME ASSESSMENT; POSITIVE SYNDROME; PRIORITY JOURNAL; PSYCHOSIS; SOCIAL ASPECT; TREATMENT OUTCOME;

ACHIEVEMENT; ADOLESCENT; ADULT; ANXIETY DISORDERS; BRAIN; COHORT STUDIES; DELUSIONS; DEPRESSIVE DISORDER; ELECTROENCEPHALOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PSYCHOMOTOR DISORDERS; PSYCHOTIC DISORDERS; SOCIAL BEHAVIOR; VERBAL BEHAVIOR;

EID: 40449087413     PISSN: 0001690X     EISSN: 16000447     Source Type: Journal    
DOI: 10.1111/j.1600-0447.2007.01120.x     Document Type: Article

References (28)

1. Clementz BA, Sponehim SR, Iacono WG, Beiser M. Resting EEG in first episode schizophrenia patients, bipolar psychosis patients, and their first-degree relatives. Psychophysiology 1994 31 : 486 494.
2. Merlo MCG, Kleinlogel H, Koukkou M. Differences in EEG profiles of early and late responders to antipsychotic treatment in first episode drug-naïve psychotic patients. Schizophr Res 1998 30 : 221 228.
3. Manchanda R, Malla A, Harricharan R, Cortese L, Takhar J. EEG abnormalities and outcome in first episode psychosis. Can J Psychiatry 2003 48 : 722 726.
4. Manchanda R, Norman R, Malla A, Harricharan R, Takhar J, Northcott S. EEG abnormalities and two year outcome in first episode psychosis. Acta Psychiatr Scand 2005a 111 : 208 213.
5. Addington J, Addington D. Premorbid functioning, cognitive functioning, symptoms and outcome in schizophrenia. J Psychiatry Neurosci 1993 18 : 18 23.
6. Larsen TK, Moe LC, Vibe-Hansen L, Johannessen JO. Premorbid functioning versus duration of untreated psychosis on 1-year outcome in first episode psychosis. Schizophr Res 2000 45 : 1 9.
7. Norman RMG, Malla AK, Manchanda R, Townsend L. Premorbid adjustment in first episode schizophrenia and schizoaffective disorders: a comparison of social and academic domains. Acta Psychiatr Scand 2005 112 : 30 39.
8. First MB, Spitzer RL, Gibbon M, Williams JB. SCID clinician version administration booklet. New York, Biometrics Research Department, NY State Psychiatric Institute, 1995.
9. Andreasen NC. Scale for Assessment of Positive Symptoms (SAPS). Iowa City : University of Iowa, 1984.
10. Andreasen NC. Scale for Assessment of Negative Symptoms (SANS). Iowa City : University of Iowa, 1983.
11. Addington D, Addingtoin J, Maticka-Tyndale E. Reliability and validity of a depression rating scale for schizophrenia. Schizophr Res 1992 6 : 201 208.
12. Riskind JH, Beck AT, Brown G, Steer RA. Taking the measure of anxiety and depression: validity of the reconstructed Hamilton Scales. J Nerv Ment Dis 1987 175 : 474 479.
13. American Psychiatric Associations : Diagnostic and statistical manual of mental disorders, 4th edn, Text Revision. Washington, DC : American Psychiatric Association, 2000.
14. Malla AK, Norman RMG, Williamson P, Cortese L, Diaz F. Three syndrome concept of schizophrenia: a factor analytic study. Schizophr Res 1993 10 : 143 150.
15. Binnie CD. Electroencephalography. Chapter 8. In : Laidlaw J, Richens A, Oxley J eds. A textbook of epilepsy. 3rd edn. London : Churchill Livingstone, 1988 : 236 306.
16. Mayo Clinic. Clinical neurophysiology. Chapter 15. In : Ahlskog JE, Aksamit AJ, Aronson AE eds. Clinical examinations in neurology. Mayo Foundation for Medical Education and Research. Mosby Year Book. St Louis, 1991 : 354 451.
17. Cannon-Spoor HE, Potkin SG, Wyatt RJ. Measurement of premorbid adjustment in chronic schizophrenia. Schizophr Bull 1982 8 : 470 484.
18. Vankammen DP, Kelley ME, Gilbertson MW, Gurklis JA, O'connor DT. CSF dopamine B-hydroxyls in schizophrenia: associations with premorbid functioning and brain computerized tomography scan measures. Am J Psychiatry 1994 151 : 372 378.
19. Hafner H, Riecher-Rossler A, Hambrecht M et al. IRAOS: an instrument for the assessment of onset and early course of schizophrenia. Schizophr Res 1992 6 : 209 223.
20. Norman RMG, Malla AK, Verdi MB, Hassall LD, Fazekas C. Understanding delay in treatment for first episode psychosis. Psychol Med 2004 34 : 255 266.
21. Rosner B. Fundamentals of biostatistics. 5th edn. Duxbury : Pacific Grove, 2000 : 511 576.
22. Itil TM, Soldatos C. Epileptogenic side effects of psychotic drugs: practical recommendation. JAMA 1990 147 : 1069 1071.
23. Centorrino F, Price BH, Tuttle M et al. EEG abnormalities during treatment with typical and atypical antipsychotics. Am J Psychiatry 2002 159 : 109 115.
24. Sponheim SR, Clementz BA, Iacono WG, Beiser M. Resting EEG in first episode and chronic schizophrenia. Psychophysiology 1994 31 : 37 43.
25. Pantelis C, Velakoulis D, Mcgorry PD et al. Neuronatomical abnormalities before and after onset of psychosis: a cross-sectional and longitudinal MRI comparison. Lancet 2003 361 : 281 288.
26. Cahn W, Van Haren NEM, Hulshoff Pol HE et al. Brain volume changes in the first year of illness and 5-year outcome of schizophrenia. Br J Psychiatry 2006 109 : 381 382.
27. Pillay SS, Stoll AL, Weiss MK et al. EEG abnormalities before clozapine therapy predict a good clinical response to clozapine. Ann Clin Psychiatry 1996 8 : 1 5.
28. Manchanda R, Norman R, Malla A, Harricharan R, Northcott S. Persistent psychosis in first episode patients. Schizophr Res 2005b 80 : 113 116.